ArticleVideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy2026
Application of a novel endoscopic ultrasound-guided motorized fine needle for liver and pancreatic lesion biopsy.
Article in VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The motorized fine-needle biopsy (mFNB) device (Precision-GI; Limaca Medical, Ein Ha Emeq, Israel) is a novel electromechanical tool designed to optimize EUS-guided tissue acquisition through controlled axial advancement and high-speed rotational coring. This study presents 2 clinical cases demonstrating the safety and effectiveness of the second-generation mFNB in obtaining liver and pancreatic biopsy samples. Methods: Two female patients underwent EUS-guided biopsies using a 20-gauge mFNB device. One patient had suspected liver disease and the other a pancreatic mass, respectively. The device was used to perform targeted tissue sampling, with emphasis on tissue adequacy, integrity, and absence of blood contamination. Results: In both cases, the mFNB allowed successful tissue acquisition without adverse events. The liver biopsy yielded a 0.5 × 0.5 × 0.2-cm specimen with 6 portal triads, confirming micronodular cirrhosis with steatosis and fibrosis. The pancreatic biopsy produced a 0.8 × 0.5 × 0.2-cm core, leading to a diagnosis of acinar cell carcinoma. Both specimens were deemed adequate and intact with no blood contamination. Conclusions: The mFNB device is safe for EUS-guided liver and pancreatic biopsies, providing high-quality tissue samples. The motorized design may reduce procedure time and improve diagnostic yield. Further comparative studies with manual fine-needle biopsy are required to validate these findings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.